Everything small molecule drug discovery should be.
About Terray
We invented a different way
Terray exists to change the way experimentation and computation work together. We believe high-quality data at scale is the key to unlocking generative AI for small molecules. Our workflow places equal emphasis on wet lab science and AI, giving us everything we need to solve the toughest therapeutic challenges.
Our Approach
A platform intentionally designed to improve the speed, cost, and success rate of small molecule drug discovery and development.
Unparalleled Scale and Speed
Our experimental dataset includes more than two billion unique target-ligand binding measurements, growing by 1 billion new measurements every quarter.
Precise Data
Each measurement is supported by an average of 25 independent data points, resulting in high resolution quantitative data that unlocks accurate molecular property prediction with deep learning regression models.
Closed-loop Iteration
A design-make-test-analyze cycle takes less than a month per target, enabling us to intelligently and smoothly explore chemical space, experimentally measuring millions of molecules at a time.
Data Rich Target Prioritization
Our platform rapidly identifies potent, selective small molecules for many targets in parallel, enabling us to evaluate multiple points of intervention in a pathway to treat disease.
Pipeline
Our internal pipeline is focused on immunology. In partnership, we apply our platform to a wide range of challenging targets and therapeutic areas with large pharma and biotech.
Join us
Our team is deeply curious, seriously inventive, and driven by data. Sound like you?
See open rolesThe latest from Terray